tiprankstipranks

Perceptive Advisors Llc Insider Profile

116 Followers
Perceptive Advisors Llc, Ten Percent Owner at Amicus, holds 10.79M shares in Cerevel Therapeutics Holdings (Ticker: CERE), holds 57.58M shares in LianBio Sponsored ADR (Ticker: LIANY), holds 6.49M shares in Astria Therapeutics (Ticker: ATXS).
tipranks
Perceptive Advisors Llc

Perceptive Advisors Llc
Amicus (FOLD)
Ten Percent Owner

Ranked #190 out of 97,825 Corporate Insiders

Profitable Transactions

47%
87 out of 187 Profitable Transactions

Average Return

+23.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2B
21.12%
17.71%
11.35%
10.91%
38.91% Others
A breakdown of Perceptive Advisors Llc's holdings

Insider Roles

Cerevel Therapeutics Holdings
(CERE)
Director
Landos Biopharma
(LABP)
Ten Percent Owner
Amicus
(FOLD)
Ten Percent Owner
Crinetics Pharmaceuticals
(CRNX)
Ten Percent Owner
+19 other positions
Roles that Perceptive Advisors Llc holds in companies

Most Profitable Insider Trade

Stock:
Soleno Therapeutics
(SLNO)
Rating:Informative Buy
Date:May 26, 2023 - Today
Return:+727.80%
The most profitable trade made by Perceptive Advisors Llc

Perceptive Advisors Llc's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Amicus
Oct 05, 2018
Ten Percent Owner
Informative Buy
629.70K
$245.79M
ARAV
Aravive
Sep 25, 2017
Informative Sell
7.00M
$151.90K
CORI
Corium
Oct 15, 2018
Informative Sell
45.46M
$34.55M
ZGNX
Zogenix
Aug 14, 2018
Informative Buy
5.20M
$108.60M
QTNTQ
Quotient
Nov 02, 2022
Informative Sell
660.45K
$309.86K
GBT
Global Blood Therapeutics
Dec 19, 2017
Informative Buy
6.65M
$334.85M
ALBO
Albireo Pharma
Oct 13, 2022
Informative Sell
9.51M
$85.64M
Solid Biosciences
Jan 12, 2024
Director, Ten Percent Owner
Informative Buy
18.86M
$98.42M
LJPC
La Jolla Pharma
Jan 09, 2019
Informative Sell
11.72M
$14.02M
Motus Gi Holdings
Jan 22, 2021
Ten Percent Owner
Informative Sell
2.53M
$1.11M
DOVA
Dova Pharmaceuticals
Nov 15, 2019
Uninformative Sell
$0.00
Meiragtx Holdings
May 15, 2023
Director, Ten Percent Owner
Informative Buy
25.00M
$70.06M
Agile Therapeutics
Oct 15, 2021
Ten Percent Owner
Informative Buy
4.87M
$8.01M
Verrica Pharmaceuticals
Dec 29, 2023
Ten Percent Owner
Informative Buy
2.31M
$40.11M
ATNXQ
Athenex
Sep 14, 2020
Informative Buy
22.05M
$202.99K
ADMA Biologics
Sep 30, 2021
Ten Percent Owner
Informative Sell
299.24K
$89.39M
KDMN
Kadmon Holdings
Nov 18, 2019
Informative Buy
5.00M
$139.05M
Crinetics Pharmaceuticals
Apr 18, 2022
Ten Percent Owner
Informative Buy
3.50M
$236.41M
Lyra Therapeutics
Jun 02, 2023
Director, Ten Percent Owner
Informative Buy
8.99M
$83.31M
VYNE Therapeutics
Aug 18, 2021
Ten Percent Owner
Informative Sell
435.00K
$14.61M
Leap Therapeutics
Jun 24, 2020
Ten Percent Owner
Informative Buy
3.50M
$23.56M
Athira Pharma
Dec 29, 2023
Director, Ten Percent Owner
Informative Buy
1.46M
$13.83M
Cerevel Therapeutics Holdings
Feb 21, 2024
Director
Uninformative Sell
$457.49M
Astria Therapeutics
Feb 05, 2024
Director
Informative Buy
30.00M
$88.20M
Landos Biopharma
Feb 09, 2021
Ten Percent Owner
Informative Buy
3.21M
$383.64M
RXDX
Prometheus Biosciences
Mar 16, 2021
Uninformative Buy
$662.54M
RAIN
Rain Oncology
Oct 13, 2021
Informative Sell
667.48K
$3.01M
Nautilus Biotechnolgy
Dec 10, 2021
Director
Informative Buy
1.07M
$25.24M
ISO
IsoPlexis
Oct 14, 2021
Uninformative Buy
$3.12M
LianBio Sponsored ADR
Feb 20, 2024
Director, Ten Percent Owner
Uninformative Sell
182.96K
$17.62M
Soleno Therapeutics
Sep 28, 2023
Ten Percent Owner
Informative Buy
15.11M
$131.74M
CARGO Therapeutics, Inc.
Nov 14, 2023
Former 10% Owner
Uninformative Buy
$7.47M
Talphera
Jun 21, 2017
Ten Percent Owner
Informative Sell
2.10M
$6.60M
Aldeyra Therapeutics
Oct 18, 2023
Ten Percent Owner
Informative Sell
4.45M
$26.47M
VBI Vaccines
Apr 06, 2023
Ten Percent Owner
Informative Sell
1.48M
$24.04M
Heron Therapeutics
Jul 07, 2011
Ten Percent Owner
Informative Buy
$73.07M
AEGR
Aegerion
Sep 09, 2013
Informative Buy
5.00M
$5.56M
~RPRX
Repros
Mar 19, 2013
Informative Sell
25.25M
$544.42K
GEVA
Synageva
Nov 08, 2011
Uninformative Sell
List of latest transactions for each holding click on a transaction to see Perceptive Advisors Llc's performance on stock

Perceptive Advisors Llc insider profile FAQ

What is the percentage of profitable transactions made by Perceptive Advisors Llc?
The percentage of profitable transactions made by Perceptive Advisors Llc is 47%.
    What is the average return per transaction made by Perceptive Advisors Llc?
    The average return per transaction made by Perceptive Advisors Llc is 23.10%.
      What stocks does Perceptive Advisors Llc hold?
      Perceptive Advisors Llc holds: FOLD, ARAV, CORI, ZGNX, QTNTQ, GBT, ALBO, SLDB, LJPC, MOTS, DOVA, MGTX, AGRX, VRCA, ATNXQ, ADMA, KDMN, CRNX, LYRA, VYNE, LPTX, ATHA, CERE, ATXS, LABP, RXDX, RAIN, NAUT, ISO, LIANY, SLNO, CRGX, TLPH, ALDX, VBIV, HRTX, AEGR, ~RPRX, GEVA stocks.
        What was Perceptive Advisors Llc’s latest transaction?
        Perceptive Advisors Llc latest transaction was an Uninformative Sell of ―.
          What was Perceptive Advisors Llc's most profitable transaction?
          Perceptive Advisors Llc’s most profitable transaction was an Informative Buy of SLNO stock on May 26, 2023. The return on the trade was 727.80%.
            What is Perceptive Advisors Llc's role in Amicus?
            Perceptive Advisors Llc's role in Amicus is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.